BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9174050)

  • 1. Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.
    Simpson S; Woodworth CD; DiPaolo JA
    Oncogene; 1997 May; 14(18):2149-57. PubMed ID: 9174050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. erg, an ets-related gene, codes for sequence-specific transcriptional activators.
    Reddy ES; Rao VN
    Oncogene; 1991 Dec; 6(12):2285-9. PubMed ID: 1766675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
    Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
    Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
    Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
    Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.
    Nürnberg W; Artuc M; Vorbrueggen G; Kalkbrenner F; Moelling K; Czarnetzki BM; Schadendorf D
    Br J Cancer; 1995 May; 71(5):1018-24. PubMed ID: 7734293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the ets genes and their products.
    Watson DK; Ascione R; Papas TS
    Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation.
    Weijzen S; Zlobin A; Braid M; Miele L; Kast WM
    J Cell Physiol; 2003 Mar; 194(3):356-62. PubMed ID: 12548555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
    Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
    Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ERG is a proto-oncogene with mitogenic and transforming activity.
    Hart AH; Corrick CM; Tymms MJ; Hertzog PJ; Kola I
    Oncogene; 1995 Apr; 10(7):1423-30. PubMed ID: 7731694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
    Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
    J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.
    Kim CY; Tsai MH; Osmanian C; Graeber TG; Lee JE; Giffard RG; DiPaolo JA; Peehl DM; Giaccia AJ
    Cancer Res; 1997 Oct; 57(19):4200-4. PubMed ID: 9331075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
    Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
    Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sea urchin erg homolog defines a highly conserved erg-specific domain.
    Qi S; Chen ZQ; Papas TS; Lautenberger JA
    DNA Seq; 1992; 3(2):127-9. PubMed ID: 1457815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.
    Baldus CD; Liyanarachchi S; Mrózek K; Auer H; Tanner SM; Guimond M; Ruppert AS; Mohamed N; Davuluri RV; Caligiuri MA; Bloomfield CD; de la Chapelle A
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3915-20. PubMed ID: 15007164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERG upregulation and related ETS transcription factors in prostate cancer.
    Rostad K; Mannelqvist M; Halvorsen OJ; Oyan AM; Bø TH; Stordrange L; Olsen S; Haukaas SA; Lin B; Hood L; Jonassen I; Akslen LA; Kalland KH
    Int J Oncol; 2007 Jan; 30(1):19-32. PubMed ID: 17143509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.